Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) study

BACKGROUND: Statin treatment is a potent lipid‐lowering therapy associated with decreased cardiovascular risk and mortality. Recent studies including the PARADIGM trial have demonstrated the impact of statins on promoting calcified coronary plaque. HYPOTHESIS: The degree of systemic inflammation imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Colin, Lateef, Sundus S., Hong, Christin G., Dey, Amit K., Manyak, Grigory A., Patel, Nidhi H., Zhou, Wunan, Sorokin, Alexander V., Abdelrahman, Khaled, Uceda, Domingo, Teklu, Meron, Wu, Colin, Parel, Philip M., Sandfort, Veit, Chen, Marcus Y., Mallek, Marissa, Ahlman, Mark, Bluemke, David, Mehta, Nehal N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175258/
https://www.ncbi.nlm.nih.gov/pubmed/35366378
http://dx.doi.org/10.1002/clc.23808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175258/
https://www.ncbi.nlm.nih.gov/pubmed/35366378
http://dx.doi.org/10.1002/clc.23808

Ejemplares similares